NCT04168255 (IRB) is a NA clinical trial of Double tamponade in Retinal Detachment, sponsored by Minia University.

Who is sponsoring NCT04168255?

NCT04168255 is sponsored by Minia University.

What drugs are being tested in NCT04168255?

Interventions in NCT04168255: Double tamponade.

What condition does NCT04168255 study?

NCT04168255 studies Retinal Detachment.

Is NCT04168255 still recruiting?

NCT04168255 is currently completed. Last updated 19 November 2019.

Last reviewed 2019-11-19 · How we verify

NCT04168255: IRB

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Double Retinal Tamponade for Retinal Detachment With PVR and Inferior Breaks.

Completed NA Last updated 19 November 2019

What this trial tests

NA trial testing Double tamponade in Retinal Detachment in 30 participants. Completed in 30 August 2019.

Timeline

1 October 2017

Primary endpoint
30 August 2019

30 August 2019

Quick facts

Lead sponsor	Minia University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	30
Start date	1 October 2017
Primary completion	30 August 2019
Estimated completion	30 August 2019
Sites	1 location across Egypt

Drugs / interventions tested

Double tamponade

Conditions studied

Retinal Detachment — all drugs for Retinal Detachment →

Sponsor

Minia University

Who can join

Adults 18 to 64, any sex, with Retinal Detachment. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Purpose To evaluate the efficacy of perfluorocarbone liquids (PFCLs) for tamponading lower retinal breaks to achieve retinal reattachment in eyes of retinal detachment with proliferative vitreoretinopathy (PVR) and inferior breaks. Patients and methods The study was prospective non comparative interventional study. It included thirty eyes of 30 patients suffering from retinal detachment with proliferative vitreoretinopathy and inferior breaks attending the ophthalmology department at Minia University Hospital. The mean age was 50.2± 10.63 years, 18 females and 12 males. Double retinal tamponade procedure were done and the patients were followed for one year. The primary outcome was to achieve successful retinal reattachment and the secondary outcome is to achieve improvement in the postoperative visual acuity.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Double Retinal Tamponade for Treatment of Rhegmatogenous Retinal Detachment with Proliferative Vitreoretinopathy and Inferior Breaks.
Farouk Abdelkader M, Abd-Elhamid Mehany Elwan S, Shawkat Abdelhalim A. · · 2020 · cited 5× · PMID 33083050 · DOI 10.1155/2020/6938627

Verify or expand the search:

Other recruiting trials for Retinal Detachment

Currently open trials in the same condition.

NCT06587945 — Nicotinamide Riboside Oral Supplementation in Macula Off Retinal Detachment · Phase 4 · recruiting
NCT06985030 — Head Position Monitoring After Pars Planar Vitrectomy · active not recruiting
NCT06830070 — Subjective Pain Scoring for Subtenonal Anesthesia During Vitrectomy · active not recruiting
NCT03713268 — Intraoperative OCT Guidance of Intraocular Surgery II · recruiting

Other Minia University trials

Trials by the same sponsor.

NCT07525687 — Temporary Uterine Tourniquet Application Versus Local Myometrial Epinephrine Injection During Laparoscopic Myomectomy · NA · not yet recruiting
NCT07525674 — Vacuum Sealing Drainage (VSD) in Promoting Wound Healing and Reducing Complications in Post-Infected Obstetric and Gynec · NA · not yet recruiting
NCT07529587 — Laparoscopic Umbilico-uterine Trunk Clipping Approach in the Management of Enhanced Myometrial Vascularity · NA · not yet recruiting
NCT07500558 — Ultrasound Guided Infratemporal Sphenopalatine Ganglion Supravoltage Versus Standard Voltage Pulsed Radiofrequency for P · NA · not yet recruiting
NCT07428057 — Postoperative Hypocalcemia After Thyroidectomy · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04168255 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Minia University
Last refreshed: 19 November 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04168255.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing